ZNTL — Zentalis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview
Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview
Brief: Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Estée Lauder, IBM, Meta
Zentalis Pharma tumbles on cancer drug durability concerns
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Zentalis Pharmaceuticals Inc reports results for the quarter - Earnings Summary
Brief: Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies Of Azenosertib
Zentalis Pharmaceuticals Inc expected to post a loss of 91 cents a share - Earnings Preview
Zentalis Pharmaceuticals Inc expected to post a loss of 91 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-FedEx, Carvana, Sprouts Farmers Market, Ascendis Pharma
U.S. STOCKS ON THE MOVE-Charles Schwab, CACI International, Icahn Enterprises
U.S. STOCKS ON THE MOVE-Bausch + Lomb, Alcoa, crypto stocks
Zentalis Pharma gains as FDA lifts partial clinical hold on cancer drug studies
Brief: Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold On Azenosertib Studies
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
Zentalis Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Zentalis Pharmaceuticals Q2 EPS USD -1.24